Background The comparative effectiveness of percutaneous closure of patent foramen ovale
(PFO) plus medical therapy versus medical therapy alone for cryptogenic stroke is uncertain …

NOVEMBER 13, 2017: 2227–3 0 2228 meta-analysis of the earlier 3 randomized trials,
percutaneous PFO closure was superior to medical therapy for secondary prevention of …

Objectives: This study sought to perform a meta-analysis of randomized controlled trials
comparing device closure with medical therapy in the prevention of recurrent neurological …

This article has been corrected. The original version (PDF) is appended to this article as a
Supplement. Background: The optimal strategy for preventing recurrent stroke in patients …

Objectives: The purpose of this study was to compare the efficacy of medical treatment with
percutaneous closure of patent foramen ovale (PFO). Background: Patients with cryptogenic …

Background: New evidence emerged recently regarding the percutaneous closure of patent
foramen ovale (PFO) to prevent recurrent stroke in patients with cryptogenic stroke. Purpose …

Background: Recent reports showing the favorable role of patent foramen ovale (PFO)
closure in patients with cryptogenic stroke have raised the issue of selecting optimal …

Background Whether closure of a patent foramen ovale is effective in the prevention of
recurrent ischemic stroke in patients who have had a cryptogenic stroke is unknown. We …

Aims The efficacy of patent foramen ovale (PFO) closure for cryptogenic stroke has been
controversial. We undertook a meta-analysis of randomized controlled trials (RCTs) …

Objective: To update the 2004 American Academy of Neurology guideline for patients with
stroke and patent foramen ovale (PFO) by addressing whether (1) percutaneous closure of …